Emulate’s Lorna Ewart, Chief Scientific Officer, and Daniel Levner, Chief Technology Officer, will speak at tomorrow’s HOPE-meets-Industry conference! The HOPE program aspires to recreate human organs using the power of bioengineering. As such, the success of the program would be incredibly promising for improving cancer, autoimmune, and infectious disease interventions. Eventually, this could even mean bioengineered, immune-tolerant functional tissues capable of being transplanted into humans.
This is one of the many programs by Wellcome Leap, a non-profit dedicated to carrying out bold, unconventional programs that seek to deliver breakthroughs in human health over 5-10 years.